BOM:524572 (India)
Â
Shs Dematerialised
₹
31.32
+0.58 (+1.89%)
Aug 25
Business Description
Pharmaids Pharmaceuticals Ltd
ISIN : INE117D01018
Share Class Description:
BOM:524572: Shs DematerialisedTotal Employee Number:
28Compare
Compare
Traded in other countries / regions
524572.India IPO Date
2001-09-04Description
Pharmaids Pharmaceuticals Ltd is an Indian pharmaceutical company that manufactures specialty chemicals, skin care products, hospital care products, and generic drugs. Its product range includes vitamins and related compounds, hand sanitizers, antiseptic solutions, ointments, and various bulk drugs. The company operates from Hyderabad, India, serving domestic and select international markets. Pharmaids generates revenue prominently from the sale of these pharmaceutical and healthcare products. Its operations focus on manufacturing and supplying formulations across healthcare and personal care segments.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.12 | |||||
Equity-to-Asset | 0.55 | |||||
Debt-to-Equity | 0.49 | |||||
Debt-to-EBITDA | -13.24 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 1.61 | |||||
Beneish M-Score | -2.44 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 26.5 | |||||
3-Year EPS without NRI Growth Rate | 13.4 | |||||
3-Year FCF Growth Rate | 18.3 | |||||
3-Year Book Growth Rate | 8.9 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 31.61 | |||||
9-Day RSI | 38.21 | |||||
14-Day RSI | 42.75 | |||||
3-1 Month Momentum % | 10.27 | |||||
6-1 Month Momentum % | -12.9 | |||||
12-1 Month Momentum % | -50.75 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.46 | |||||
Quick Ratio | 0.44 | |||||
Cash Ratio | 0.12 | |||||
Days Inventory | 132.27 | |||||
Days Sales Outstanding | 73.23 | |||||
Days Payable | 258.24 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -18 | |||||
Shareholder Yield % | 4.57 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 39.76 | |||||
Operating Margin % | -42.69 | |||||
Net Margin % | -18.01 | |||||
EBITDA Margin % | -6.97 | |||||
FCF Margin % | -33.66 | |||||
OCF Margin % | -16.01 | |||||
ROE % | -8.62 | |||||
ROA % | -4.48 | |||||
ROIC % | -7.22 | |||||
3-Year ROIIC % | -3.84 | |||||
ROC (Joel Greenblatt) % | -10.53 | |||||
ROCE % | -4.94 | |||||
Years of Profitability over Past 10-Year | 4 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 4.37 | |||||
PB Ratio | 2.32 | |||||
Price-to-Tangible-Book | 6.81 | |||||
EV-to-EBIT | -35.68 | |||||
EV-to-EBITDA | -74.2 | |||||
EV-to-Revenue | 5.17 | |||||
EV-to-FCF | -15.12 | |||||
Earnings Yield (Greenblatt) % | -2.81 | |||||
FCF Yield % | -7.72 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Pharmaids Pharmaceuticals Ltd Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 253.402 | ||
| EPS (TTM) (₹) | -1.28 | ||
| Beta | -0.0659 | ||
| 3-Year Sharpe Ratio | -0.06 | ||
| 3-Year Sortino Ratio | -0.1 | ||
| Volatility % | 49.9 | ||
| 14-Day RSI | 42.75 | ||
| 14-Day ATR (₹) | 2.872448 | ||
| 20-Day SMA (₹) | 32.7825 | ||
| 12-1 Month Momentum % | -50.75 | ||
| 52-Week Range (₹) | 25.6 - 66 | ||
| Shares Outstanding (Mil) | 35.27 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Pharmaids Pharmaceuticals Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Pharmaids Pharmaceuticals Ltd Stock Events
| Event | Date | Price (₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Pharmaids Pharmaceuticals Ltd Frequently Asked Questions
What is Pharmaids Pharmaceuticals Ltd(BOM:524572)'s stock price today?
The current price of BOM:524572 is ₹31.32. The 52 week high of BOM:524572 is ₹66.00 and 52 week low is ₹25.60.
When is next earnings date of Pharmaids Pharmaceuticals Ltd(BOM:524572)?
The next earnings date of Pharmaids Pharmaceuticals Ltd(BOM:524572) is .
Does Pharmaids Pharmaceuticals Ltd(BOM:524572) pay dividends? If so, how much?
Pharmaids Pharmaceuticals Ltd(BOM:524572) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Pharmaids Pharmaceuticals Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers